In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ex-Shire Team Builds New Euro-Specialty Group

Executive Summary

Archimedes joins a growing new generation of pan-European specialty pharma, highlighting the need for a single commercial partner across Europe and the increasing alternatives to big and mid-sized pharma.
Advertisement

Related Content

Europe's New Spec Pharma Models
Cephalon: Can Spec Pharma do R&D?
Shire: Proving the Specialty Model
Intendis: Mid-Sized Specialist Spawns Small Specialist
In-Licensing in Specialty Pharma, Revisited
In-Licensing in Specialty Pharma, Revisited
Chroma: Next Generation UK Biotech
Investing Warburg Pincus Style
Biotech's Euro-Marketing Gambit
Biotech's Euro-Marketing Gambit

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV002525

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel